Strs Ohio boosted its holdings in shares of Anterix Inc. (NASDAQ:ATEX – Free Report) by 132.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,500 shares of the company’s stock after buying an additional 15,100 shares during the period. Strs Ohio’s holdings in Anterix were worth $578,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. GABELLI & Co INVESTMENT ADVISERS INC. raised its holdings in Anterix by 219.3% during the third quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 52,200 shares of the company’s stock worth $1,121,000 after buying an additional 35,850 shares during the last quarter. SBI Securities Co. Ltd. raised its holdings in Anterix by 374,815.0% during the third quarter. SBI Securities Co. Ltd. now owns 74,983 shares of the company’s stock worth $1,610,000 after buying an additional 74,963 shares during the last quarter. SG Americas Securities LLC acquired a new position in Anterix during the fourth quarter worth $1,059,000. Gamco Investors INC. ET AL raised its holdings in Anterix by 17.1% during the third quarter. Gamco Investors INC. ET AL now owns 320,070 shares of the company’s stock worth $6,872,000 after buying an additional 46,645 shares during the last quarter. Finally, Gabelli Funds LLC raised its holdings in Anterix by 52.2% during the third quarter. Gabelli Funds LLC now owns 286,282 shares of the company’s stock worth $6,146,000 after buying an additional 98,130 shares during the last quarter. Institutional investors and hedge funds own 87.67% of the company’s stock.
Analysts Set New Price Targets
ATEX has been the topic of several research reports. Zacks Research downgraded shares of Anterix from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 5th. Weiss Ratings upgraded shares of Anterix from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, April 21st. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Anterix has an average rating of “Hold” and a consensus price target of $50.00.
Anterix Price Performance
Shares of ATEX stock opened at $55.92 on Friday. The firm has a 50-day moving average of $40.57 and a 200-day moving average of $29.41. The company has a market cap of $1.05 billion, a P/E ratio of 12.86 and a beta of 0.86. Anterix Inc. has a one year low of $17.58 and a one year high of $56.10.
Anterix (NASDAQ:ATEX – Get Free Report) last announced its earnings results on Wednesday, February 11th. The company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.57) by $0.22. The company had revenue of $1.57 million during the quarter, compared to the consensus estimate of $1.47 million. Anterix had a net margin of 1,370.92% and a negative return on equity of 12.26%. As a group, research analysts expect that Anterix Inc. will post -1.53 earnings per share for the current fiscal year.
Anterix Company Profile
Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.
At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.
Further Reading
Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEX – Free Report).
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.
